These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2052743)

  • 1. Influence of chlorpromazine on the toxicity of pirarubicin in mice.
    Maekawa I; Shibata H; Furusawa S; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Apr; 72(1):105-8. PubMed ID: 2052743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chlorpromazine on the toxicity of doxorubicin in mice.
    Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):381-4. PubMed ID: 2047578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
    Greish K; Nagamitsu A; Fang J; Maeda H
    Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of chlorpromazine, bleomycin and WR-2721 singly or in combination on the formation of radiation-induced micronuclei in mice bone marrow.
    Jagetia GC
    Strahlenther Onkol; 1994 Nov; 170(11):648-53. PubMed ID: 7526477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against doxorubicin toxicity in mice by chlorpromazine hypothermia.
    Gailis L
    Res Commun Chem Pathol Pharmacol; 1986 Sep; 53(3):319-30. PubMed ID: 3775102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of doxorubicin toxicity by chlorpromazine in male ddY mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1991 Jun; 56(2):221-4. PubMed ID: 1881001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
    Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radio-and chemotoxicity in mice during hypothermia.
    Lundgren-Eriksson L; Palm A; Ryd W; Warnhammar E; Hultborn R
    Anticancer Res; 2001; 21(5):3269-74. PubMed ID: 11848482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo.
    Tarazona R; González-García A; Zamzami N; Marchetti P; Frechin N; Gonzalo JA; Ruiz-Gayo M; van Rooijen N; Martínez C; Kroemer G
    J Immunol; 1995 Jan; 154(2):861-70. PubMed ID: 7814889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pirarubicin (THP-adriamycin)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2819-27. PubMed ID: 3046496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel lipid hybrid albumin nanoparticle greatly lowered toxicity of pirarubicin.
    Zhou J; Zhang X; Li M; Wu W; Sun X; Zhang L; Gong T
    Mol Pharm; 2013 Oct; 10(10):3832-41. PubMed ID: 23947777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
    Izumi H; Hirano S; Matsushita Y; Iguchi H; Tone H; Takeuchi T
    Cancer Biochem Biophys; 1994 Sep; 14(2):137-49. PubMed ID: 7889494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.
    Hirano S; Wakazono K; Agata N; Iguchi H; Tone H
    Drugs Exp Clin Res; 1994; 20(4):153-60. PubMed ID: 7813387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases.
    Daruwalla J; Greish K; Malcontenti-Wilson C; Muralidharan V; Iyer A; Maeda H; Christophi C
    J Vasc Res; 2009; 46(3):218-28. PubMed ID: 18953175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of chlorpromazine on the skeletal muscle--a study using skinned single fibers of the guinea pig].
    Yoshida K
    Masui; 2000 May; 49(5):484-90. PubMed ID: 10846378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of doxorubicin linked to poly-L-aspartic acid on normal murine hematopoietic progenitor cells.
    Bogliolo G; Muzzulini C; Lerza R; Pannacciulli I
    Cancer Treat Rep; 1986 Nov; 70(11):1275-81. PubMed ID: 3768872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice.
    Bertini R; Garattini S; Delgado R; Ghezzi P
    Immunology; 1993 Jun; 79(2):217-9. PubMed ID: 8102118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.